Wendy Yang

Wendy Yang has extensive experience in corporate development and strategy within the biotech sector, currently serving at Overland Pharmaceuticals since July 2020. Prior to this role, Wendy worked as a consultant at Putnam Associates, a top strategy consulting firm for healthcare clients. Wendy's earlier research experience includes positions at Yale University School of Medicine, contributing to a publication in *Science Translational Medicine*, and at Georgia Institute of Technology. Wendy Yang holds an MBA from Stanford University Graduate School of Business and a Bachelor of Science in Molecular, Cellular, and Developmental Biology from Yale University, graduating Cum Laude with a GPA of 3.87.